Clinical Trial Update: Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether L-Arginine can prevent progression to Type 2 Diabetes Mellitus in people with metabolic syndrome and impaired glucose tolerance;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Impaired Glucose Tolerance
• Insulin Resistance
• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Metabolic Syndrome, Impaired Glucose Tolerance | Phase 3 | Status: COMPLETED